News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
247 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (18745)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Cutera Names Elisha Wade Finney to its Board of Directors
Ms. Finney spent the previous 29 years with Varian Medical in positions of increasing responsibility, including serving as Executive Vice President and CFO until her retirement in 2017.
November 1, 2017
·
2 min read
Business
Intercept Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
Intercept recorded $40.9 million of worldwide net Ocaliva sales, including a change in estimate related to deferred revenue with a net effect of a one-time increase of $4.1 million in net revenue for the quarter.
November 1, 2017
·
20 min read
Genetown
Intellia Therapeutics Announces Proposed Public Offering of Common Stock
Intellia also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock.
November 1, 2017
·
3 min read
Business
Agios Reports Third Quarter 2017 Financial Results
In addition, Agios highlighted select corporate milestones and preclinical and clinical data from its development programs.
November 1, 2017
·
15 min read
Business
REGENXBIO to Host Conference Call on November 8 to Discuss Third Quarter 2017 Financial Results and Recent Operational Highlights
The will host a conference call to discuss its financial results for the quarter ended September 30, 2017 and recent operational highlights.
November 1, 2017
·
1 min read
Business
Curis to Release Third Quarter 2017 Financial Results and Hold Conference Call on November 7, 2017
The Company’s management will also host a conference call on the same day at 8:30 a.m. EST.
November 1, 2017
·
1 min read
Policy
RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT for Migraines
RIZAPORT is a proprietary oral thin-film formulation of rizatriptan for the treatment of acute migraines.
November 1, 2017
·
10 min read
Business
Edge Therapeutics Reports Third Quarter 2017 Financial Results
In addition, the company also appointed pharma vet Andrew Saik as CFO.
November 1, 2017
·
11 min read
Business
Trevena to Report Third Quarter 2017 Financial Results on November 7, 2017
To join the call, please dial-in at (855) 465-0180 (conference ID: 9796968).
November 1, 2017
·
1 min read
Deals
MediPines Acquires Oxistimulator Technology From Mayo Clinic
MediPines announced today that it has acquired medical technology designed to reduce respiratory complications in post-surgical patients by preventing oxygen desaturations.
November 1, 2017
·
2 min read
Previous
15 of 25
Next